Livestock breeding disease medication real-time follow-up management method
By adjusting the drug interval according to the specific situation of the livestock in animal husbandry, the problems of inappropriate drug intervals and insufficient drug metabolism assessment in the prior art are solved, and more scientific drug management is achieved, and the treatment effect and safety are improved.
Patent Information
- Application Number
- CN202411234463.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-04
- Publication Date
- 2024-11-29
AI Technical Summary
The existing drug follow-up management technology for animal husbandry diseases lacks a personalized adjustment mechanism, and fails to scientifically consider the real-time condition and physiological reaction of livestock, resulting in poor drug treatment effects, which may lead to a deviation in the treatment direction or cause unnecessary harm to livestock. And failed to fully evaluate drug metabolic capacity.
By retrieving the treatment information of the target livestock, determining the initial medication interval, and periodically adjusting according to the condition improvement and drug residues, judging the symptomatic effectiveness of the drug. If not, a dressing change warning will be made to ensure that the drug is in the optimal time window Exert efficacy and reduce residues.
The drug interval is adjusted according to individual differences in livestock and the development of the disease, ensuring the absorption, distribution, metabolism and excretion of drugs in the livestock, improving the therapeutic effect, reducing unnecessary drug residues, and ensuring the comprehensiveness and sustainability of the treatment plan.
Smart Images

Figure CN119049645A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of animal husbandry and breeding, and relates to a real-time follow-up management method for medication of animal husbandry and breeding diseases. Background Art
[0002] With the rapid development of modern agriculture, animal husbandry has become an important industry to ensure food safety, increase farmers' income and promote rural economic prosperity. However, in the process of animal husbandry, the occurrence and prevention of animal diseases have become one of the important factors restricting the healthy development of the industry. In order to ensure the health of farmed animals, improve production efficiency and ensure food safety, the real-time follow-up management method of animal husbandry disease medication is particularly important.
[0003] The prior art also involves related solutions such as follow-up management of livestock and breeding disease medication. For example, the invention patent application for a livestock and breeding tracking and tracing system with patent publication number CN106157063A uses a unique QR code set on the breeding body to transmit illness information and medication information to an online database through a wireless transmission scanning device. The illness information and medication information include illness time, illness cause, name, medication and treatment effect function selection, and monitor the illness process of the breeding body. Although it effectively realizes medication follow-up management, it still has the limitations that are widely present in the prior art, specifically: 1. The existing livestock and breeding disease medication follow-up management technology generally focuses on the dimensions of adapted drug selection and drug efficacy monitoring for livestock diseases, and does not carry out refined drug follow-up control of sick livestock from the dimension of medication intervals. It usually relies on the experience judgment of professionals or the basic instructions on the content of drug administration, and does not actually consider the individual differences of livestock and the differences in the development of the disease. There is a lack of a scientific and personalized adjustment mechanism based on the real-time condition and physiological reactions of sick livestock, making it difficult to ensure the effectiveness of drug treatment and the safety of livestock life.
[0004] 2. The existing follow-up management technology for livestock and breeding disease medication lacks the ability to judge the symptomatic effectiveness of therapeutic drugs based on the efficacy of the drugs at a certain stage of the disease. It ignores the differences in the responses of different livestock to drugs and blindly continues to take ineffective therapeutic drugs, which may lead to deviations in the treatment direction, delays in the disease, and even unnecessary harm to livestock. In addition, the existing technology for evaluating the efficacy of symptoms is mostly based on a single perspective of symptom improvement, and fails to explore the drug metabolism ability of sick livestock in combination with the residual drug concentration in excrement, making it impossible to understand the safety of taking therapeutic drugs. Summary of the invention
[0005] In view of this, in order to solve the problems raised in the above background technology, a real-time follow-up management method for medication of livestock breeding diseases is proposed.
[0006] The purpose of the present invention can be achieved through the following technical solutions: The present invention provides a real-time follow-up management method for livestock breeding disease medication, including: S1. Retrieving the treatment information of the target livestock in the farm treatment file, including physiological information, symptom information and treatment drug information.
[0007] S2. Determine the initial dosing interval of the target livestock therapeutic drug based on the treatment information.
[0008] S3. Administer therapeutic drugs to target livestock according to the initial medication interval, monitor the improvement of symptoms and drug residues of target livestock within a preset period, determine whether there is a need to regulate the initial medication interval of target livestock therapeutic drugs, and if so, determine the regulated medication interval of the next preset period of the target livestock.
[0009] S4. In the next preset cycle, administer the therapeutic drug to the target livestock according to the regulated medication interval, and repeat step S3.
[0010] S5. After a preset number of preset cycles, summarize the target livestock's symptom improvement status assessment indicators and drug residue status assessment indicators within each preset cycle to determine whether the therapeutic drugs are symptomatically effective for the target livestock. If it is determined that they are not, a drug change warning is issued, otherwise the therapeutic drugs continue to be taken.
[0011] Compared with the prior art, the present invention has the following beneficial effects: (1) Based on the symptomatic drug concentration threshold of the target livestock, the present invention takes the drug's own action and livestock metabolism as the entry point, and takes the severity and urgency of the disease as the correction point, to carry out personalized determination and analysis of the initial medication interval of the target livestock therapeutic drug, and more accurately predict the absorption, distribution, metabolism and excretion process of the drug in the livestock, which helps to ensure that the therapeutic drug exerts the maximum therapeutic effect within the optimal time window, while reducing unnecessary drug residues.
[0012] (2) The present invention is based on the monitoring performance of the target livestock during a preset period, analyzes the improvement of the symptoms of the target livestock after taking the therapeutic drugs for the preset period and the rationality of the residual concentration of the therapeutic drugs in the excreta, and thus develops a multi-situation discussion to determine whether there is a need to regulate the initial medication interval of the target livestock therapeutic drugs, and more comprehensively reflects the effect of the therapeutic drugs and their safety impact on livestock, thereby ensuring the comprehensiveness and sustainability of the treatment plan.
[0013] (3) The present invention determines whether the therapeutic drug is effective for the target livestock by summarizing the evaluation indicators of symptom improvement and drug residue status within a preset period of a preset number of times experienced by the target livestock. This not only ensures that the evaluation process has a sufficient time span and repeatability from the time dimension, but also more scientifically reflects the long-term effect and stability of the therapeutic drug. It also comprehensively considers the two key indicators of symptom improvement and drug residue status, and can comprehensively and objectively evaluate the efficacy of the therapeutic drug. BRIEF DESCRIPTION OF THE DRAWINGS
[0014] In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings required for describing the embodiments are briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without creative work.
[0015] Figure 1 The present invention is a flowchart of the steps for implementing the method.
[0016] Figure 2 for Figure 1 Schematic diagram of the detailed implementation steps of step S2.
[0017] Figure 3 It is a reference schematic diagram of the drug residue change curve of the target livestock of the present invention. DETAILED DESCRIPTION
[0018] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0019] See also Figure 1 As shown, the present invention provides a real-time follow-up management method for medication of livestock breeding diseases, including: S1. Retrieving treatment information of target livestock in the treatment file of the breeding farm, including physiological information, symptom information and treatment drug information.
[0020] It should be noted that the above-mentioned contents of the farm treatment files are recorded and compiled by the professional managers of the farms after detailed monitoring and drug diagnosis of sick livestock.
[0021] Specifically, the physiological information includes age and liver and kidney function indicators.
[0022] The symptom information includes the initial representation content and the current representation content of the symptom onset.
[0023] The therapeutic drug information includes the drug name, the drug's inherent half-life, the concentration of the active ingredient corresponding to the unit dose of the drug, the single dose of the target livestock, the type of administration route and the symptomatic drug concentration threshold, and the drug metabolism rate based on the normative reference of the target livestock species category.
[0024] It should be noted that the symptomatic drug concentration threshold for the above-mentioned target livestock refers to the minimum concentration of its therapeutic drug to maintain the therapeutic effect, and the drug metabolism rate referenced by the target livestock species category standard refers to the average metabolic rate of the target livestock species category for the therapeutic drug throughout its life cycle, which can be obtained by referring to scientific research, veterinary manuals or drug use guidelines.
[0025] S2. Determine the initial dosing interval of the target livestock therapeutic drug based on the treatment information.
[0026] See also Figure 2 As shown, specifically, the determination of the initial medication interval of the target livestock treatment drug includes: S21. taking the product of the active ingredient concentration corresponding to the unit dose of the drug and the single dose of the target livestock as the effective drug concentration of the single dose of the target livestock , set the weight of the effect of the target livestock administration route type on the drug attenuation time , combined with the intrinsic half-life of the drug and symptomatic drug concentration thresholds for target livestock Calculate the time span for the target livestock to decay to the symptomatic drug concentration threshold due to the drug's own effect after a single dose of the drug , ,in is a natural constant.
[0027] It should be noted that the basis for setting the weight of the impact of the target livestock administration route type on the drug decay time is: the types of administration routes for sick livestock in farms include but are not limited to oral administration, injection administration and topical administration, etc. Different types of administration routes will directly affect the speed of the drug entering the blood circulation, the distribution range and the efficiency of metabolic excretion, thereby further affecting the drug's decay time.
[0028] Exemplarily, the weights of the effects of oral administration, injection administration, and topical administration on the drug attenuation time can be specifically set to: 0.3, 0.5, 0.2.
[0029] S22. Extract drug metabolism rates for target livestock species , the age and liver and kidney function indicators of the target livestock, and set the correction factor for the drug metabolism level corresponding to the current age stage of the target livestock , compare the target livestock liver and kidney function index with the target livestock species category healthy liver and kidney function index interval stored in the WEB cloud. If the target livestock liver and kidney function index is within the target livestock species category healthy liver and kidney function index interval, the impact weight of the target livestock liver and kidney function index on the drug metabolism level is set to 0, otherwise it is set to the deviation ratio of the target livestock liver and kidney function index and the target livestock species category healthy liver and kidney function index interval, thereby obtaining the impact weight of the target livestock liver and kidney function index on the drug metabolism level. , according to the formula Analyze the time span for the target livestock to decay to the symptomatic drug concentration threshold due to livestock metabolism after a single dose of the drug.
[0030] It should be noted that the basis for setting the correction factor of the drug metabolism level corresponding to the current age stage of the target livestock is that the changes in the physiological function, organ development level and metabolic activity of the target livestock at different age stages will directly affect the absorption, distribution, metabolism and excretion of the drug in the body, thereby affecting the metabolic rate of the drug. The target livestock's various age stages specifically include the juvenile stage, adult stage and elderly stage. The corresponding age ranges can be specifically referred to the veterinary manuals, academic literature or industry guidelines related to the target livestock species category. Under normal circumstances, the drug metabolism levels in the juvenile stage, adult stage and elderly stage decrease in sequence, and the drug metabolism rate referenced by the target livestock species category specification is the average metabolic rate of the target livestock species category for therapeutic drugs throughout its life cycle. By way of example, the correction factors for drug metabolism levels in the juvenile stage, adult stage and elderly stage can be set to 1.3, 1 and 0.7.
[0031] S23. Analyze the target livestock disease information and assess the urgency of the target livestock disease and severity of symptoms , and the reference evaluation threshold of the urgency of livestock diseases stored in the WEB cloud and severity of symptoms according to the evaluation threshold Carry out comparative analysis and calculate the comprehensive evaluation coefficient of the current disease of the target livestock , , according to the formula Determine the initial dosing interval for target livestock therapeutics.
[0032] Specifically, the evaluation of the current urgency and severity of the symptoms of the target livestock includes: a livestock symptom keyword library with integrated symptom classification management based on WEB cloud storage and preset symptom evaluation weight factors for each symptom severity level, retrieving each matching symptom keyword and its preset symptom evaluation weight factor corresponding to the symptom severity level in the current representation content of the symptom onset in the symptom information of the target livestock, accumulating the current symptom severity of the target livestock, and similarly analyzing the initial symptom severity of the target livestock based on the initial representation content of the symptom onset in the symptom information of the target livestock.
[0033] Search whether there are life-threatening disease keywords in the current representation content of the target livestock's disease onset, so as to analyze the current disease urgency factors of the target livestock.
[0034] It should be noted that whether there are life-threatening disease keywords in the current representation content of the above-mentioned target livestock disease attack is still based on the clearly specified life-threatening disease keywords in the livestock disease keyword library of integrated disease classification management. If there are life-threatening disease keywords in the current representation content of the target livestock disease attack, the proportion of the number of life-threatening disease keywords retrieved is counted and used as the current disease urgency factor of the target livestock. Conversely, if there are no life-threatening disease keywords in the current representation content of the target livestock disease attack, the current disease urgency factor of the target livestock is directly set to 0.
[0035] According to the current and initial severity of the symptoms of the target livestock, the symptom development coefficient of the target livestock is analyzed, and the coefficient is added to the current symptom urgency factor of the target livestock to obtain the current symptom urgency of the target livestock.
[0036] It should be noted that the analysis process of the above-mentioned target livestock symptom development coefficient is as follows: calculate the span from the start time of the target livestock symptom onset to the current time of the symptom onset, perform a ratio analysis on the difference between the current and initial symptom severity of the target livestock and the span from the start time of the target livestock symptom onset to the current time of the symptom onset, and obtain the target livestock symptom development speed, and further perform a ratio analysis with the preset reference symptom development speed to obtain the target livestock symptom development coefficient.
[0037] The embodiment of the present invention is based on the symptomatic drug concentration threshold of the target livestock, takes the drug's own effect and the livestock's metabolic effect as the entry point, and takes the severity of the disease and the urgency of the disease as the correction point, to carry out personalized determination and analysis of the initial medication interval of the target livestock therapeutic drug, and more accurately predict the absorption, distribution, metabolism and excretion process of the drug in the livestock, which helps to ensure that the therapeutic drug exerts the maximum therapeutic effect within the optimal time window, while reducing unnecessary drug residues.
[0038] S3. Administer therapeutic drugs to target livestock according to the initial medication interval, monitor the improvement of symptoms and drug residues of target livestock within a preset period, determine whether there is a need to regulate the initial medication interval of target livestock therapeutic drugs, and if so, determine the regulated medication interval of the next preset period of the target livestock.
[0039] It should be noted that the above-mentioned preset period is specifically set to one day in the present invention, that is, the present invention adopts an alternate-day medication interval control mechanism to continuously follow up on the management of livestock medication in breeding farms.
[0040] Specifically, the monitoring of the improvement of the symptoms of the target livestock within the preset period includes: collecting the symptoms of the target livestock at the end of the preset period, analyzing the severity of the symptoms of the target livestock at the end of the preset period and urgency of the condition , build a matrix based on the current severity and urgency of the disease in the target livestock , the matrix determinant calculation value is used as the evaluation index of the improvement of the disease status of the target livestock within the preset period .
[0041] Specifically, the monitoring of drug residue status of target livestock within a preset period includes: collecting excrement samples of target livestock at each excretion within the preset period, monitoring the residual concentration of therapeutic drugs therein, screening out the maximum value therefrom and performing ratio analysis with the preset reasonable excretion residual concentration threshold of therapeutic drugs stored in the WEB cloud, and using the ratio analysis calculated value as an evaluation index of drug residue status of target livestock within the preset period .
[0042] Specifically, the determination of whether there is a need to regulate the initial medication interval of the target livestock treatment drug includes: the product of the current urgency of the target livestock's disease and the severity of the disease is recorded as .
[0043] like , If it is the preset calculation allowable deviation threshold, it means that the target livestock has recovered after taking the preset cycle of therapeutic drugs and no longer needs to take the drugs. It is judged that there is a need to regulate the initial medication interval of the target livestock therapeutic drugs, and the regulated medication interval is automatically set to NULL.
[0044] It should be noted that the above-mentioned automatic setting and regulation of medication interval is a NULL virtual item. After automatic setting, it is necessary to immediately confirm the recovery of the target livestock with the professional management personnel of the farm. After manual confirmation that the target livestock has recovered, the NULL virtual item will be converted into a real item.
[0045] like and , it means that the target livestock’s symptoms have improved but not yet recovered after taking the therapeutic drugs for the preset period, the residual concentration of the therapeutic drugs in the excreta is normal, and there is no need to adjust the initial medication interval of the target livestock’s therapeutic drugs.
[0046] like and , it means that the target livestock’s symptoms have improved but not yet recovered after taking the therapeutic drugs for the preset period, the residual concentration of the therapeutic drugs in the excreta is abnormal, and there is a need to adjust the initial medication interval of the target livestock therapeutic drugs and the regulation direction is upward.
[0047] like and , it means that the symptoms of the target livestock have not improved after taking the therapeutic drugs for the preset period, the residual concentration of the therapeutic drugs in the excrement is normal, and there is a need to adjust the initial medication interval of the target livestock therapeutic drugs and the regulation direction is downward.
[0048] like and , it means that the symptoms of the target livestock have not improved after taking the therapeutic drugs for the preset period, the residual concentration of the therapeutic drugs in the excrement is abnormal, and there is a need to adjust the initial medication interval of the target livestock therapeutic drugs and the regulation direction is upward.
[0049] Specifically, the determining of the regulation medication interval of the next preset cycle of the target livestock includes: extracting the reference duration of the regulation of the single medication interval of the drug stored in the WEB cloud; if it is determined that the regulation direction of the initial medication interval of the target livestock treatment drug is upward, then accumulating the initial medication interval of the target livestock treatment drug and the reference duration of the single medication interval regulation of the drug to obtain the regulation medication interval of the next preset cycle of the target livestock.
[0050] If it is determined that the regulation direction of the initial medication interval of the target livestock treatment drug is downward, the initial medication interval of the target livestock treatment drug is subtracted from the benchmark duration of the single medication interval regulation of the drug to obtain the regulated medication interval of the next preset cycle of the target livestock.
[0051] The embodiment of the present invention is based on the monitoring performance of the target livestock during a preset period, analyzes the improvement of the symptoms of the target livestock after taking the therapeutic drugs for the preset period and the rationality of the residual concentration of the therapeutic drugs in the excreta, and conducts a multi-situation discussion to determine whether there is a need to regulate the initial medication interval of the target livestock therapeutic drugs, more comprehensively reflects the effect of the therapeutic drugs and their safety impact on the livestock, thereby ensuring the comprehensiveness and sustainability of the treatment plan.
[0052] S4. In the next preset cycle, administer the therapeutic drug to the target livestock according to the regulated medication interval, and repeat step S3.
[0053] S5. After a preset number of preset cycles, summarize the target livestock's symptom improvement status assessment indicators and drug residue status assessment indicators within each preset cycle to determine whether the therapeutic drugs are symptomatically effective for the target livestock. If it is determined that they are not, a drug change warning is issued, otherwise the therapeutic drugs continue to be taken.
[0054] It should be noted that the reason for judging whether the therapeutic drug is symptomatically effective for the target livestock after a preset number of preset cycles is that the alternate-day medication interval control mechanism adopted in the present invention may not be sufficient to fully reflect the actual efficacy of the drug simply by relying on the symptom improvement evaluation index and drug residue evaluation index within one day. Specifically, even if it is observed that the symptoms of the target livestock have not been significantly improved after taking the therapeutic drug within one day, and the concentration of the therapeutic drug residue in the excrement is abnormal, it is not enough to immediately conclude that the drug is ineffective or has been used improperly. Therefore, the efficacy of the drug is evaluated on the basis of a preset number of preset cycles to allow the drug to fully exert its effect in the animal body and show its therapeutic or preventive effect.
[0055] See also Figure 3 Specifically, the method of determining whether the therapeutic drug is effective for the target livestock includes: drawing a drug residue change curve of the target livestock and obtaining the corresponding best fitting function. .
[0056] It should be noted that the drug residue change curve of the above-mentioned target livestock can be imported into Matlab software, and the best fitting tool in the software can be used to obtain the best fitting function corresponding to the curve.
[0057] Extract the start and end time of the curve and end endpoint time , according to the formula Analyze the effective metabolic coefficient of target livestock for therapeutic drugs.
[0058] Calculate the growth rate of the target livestock's disease improvement evaluation index in each preset period relative to the previous preset period, and calculate the effective improvement coefficient of the therapeutic drug on the target livestock's disease through mean calculation .
[0059] Will , The products of the corresponding preset weights are accumulated respectively. If the accumulated value is greater than or equal to the threshold value of the drug symptomatic effectiveness evaluation standard stored in the WEB cloud, it is judged that the therapeutic drug has symptomatic effectiveness for the target livestock, otherwise it is judged that it does not have symptomatic effectiveness.
[0060] Specifically, the drawing of the drug residue change curve of the target livestock includes: substituting the drug residue status evaluation index of the target livestock in each preset period into a rectangular coordinate system with time as the horizontal axis, the preset period as the unit horizontal axis span, and the drug residue status evaluation index as the vertical axis, so as to draw the drug residue change curve of the target livestock.
[0061] The embodiment of the present invention determines whether the therapeutic drug is symptomatically effective for the target livestock by summarizing the symptom improvement evaluation indicators and drug residue evaluation indicators experienced by the target livestock within a preset period of a preset number of times. This not only ensures that the evaluation process has a sufficient time span and repeatability from a time dimension, but also more scientifically reflects the long-term effect and stability of the therapeutic drug. It also comprehensively considers the two key indicators of symptom improvement and drug residue, and can comprehensively and objectively evaluate the efficacy of the therapeutic drug.
[0062] The above contents are merely examples and explanations of the concept of the present invention. Those skilled in the art may make various modifications or additions to the specific embodiments described or replace them in a similar manner. As long as they do not deviate from the concept of the invention or exceed the scope defined by the present invention, they shall all fall within the protection scope of the present invention.
Claims
1. A real-time follow-up management method for medication of livestock breeding diseases, characterized in that: The method includes: S1. Retrieve the treatment information of the target livestock in the farm treatment file, including physiological information, disease information and treatment drug information; S2. Determine the initial medication interval of the target livestock therapeutic drug based on the treatment information; S3. administer therapeutic drugs to the target livestock according to the initial medication interval, monitor the improvement of the symptoms of the target livestock and the drug residue status within the preset period, determine whether there is a need to regulate the initial medication interval of the target livestock, and if so, determine the regulation medication interval of the target livestock in the next preset period; S4. In the next preset cycle, administer the therapeutic drug to the target livestock according to the regulated medication interval, and repeat step S3; S5. After a preset number of preset cycles, summarize the target livestock's symptom improvement status assessment indicators and drug residue status assessment indicators within each preset cycle to determine whether the therapeutic drugs are symptomatically effective for the target livestock. If it is determined that they are not, a drug change warning is issued, otherwise the therapeutic drugs continue to be taken.
2. A real-time follow-up management method for medication for livestock breeding diseases according to claim 1, characterized in that: The physiological information includes age and liver and kidney function indicators; The symptom information includes the initial representation content and the current representation content of the symptom onset; The therapeutic drug information includes the drug name, the drug's inherent half-life, the concentration of the active ingredient corresponding to the unit dose of the drug, the single dose of the target livestock, the type of administration route and the symptomatic drug concentration threshold, and the drug metabolism rate based on the normative reference of the target livestock species category.
3. A real-time follow-up management method for medication for livestock breeding diseases according to claim 2, characterized in that: The method of determining the initial medication interval of the target livestock treatment drug includes: S21. taking the product of the concentration of the active ingredient corresponding to the unit dose of the drug and the single dose of the target livestock as the effective drug concentration of the single dose of the target livestock. , set the weight of the effect of the target livestock administration route type on the drug attenuation time , combined with the intrinsic half-life of the drug and symptomatic drug concentration thresholds for target livestock Calculate the time span for the target livestock to decay to the symptomatic drug concentration threshold due to the drug's own effect after a single dose of the drug , ,in is a natural constant; S22. Extract the drug metabolism rate, age and liver and kidney function indicators of the target livestock species, and analyze the time span for the target livestock to decay to the symptomatic drug concentration threshold due to livestock metabolism after a single dose of the drug. ; S23. Analyze the target livestock disease information and assess the urgency of the target livestock disease and severity of symptoms , and the reference evaluation threshold of the urgency of livestock diseases stored in the WEB cloud and severity of symptoms according to the evaluation threshold Carry out comparative analysis and calculate the comprehensive evaluation coefficient of the current disease of the target livestock , , according to the formula Determine the initial dosing interval for target livestock therapeutics.
4. A real-time follow-up management method for medication for livestock breeding diseases according to claim 3, characterized in that: The method of evaluating the current urgency and severity of the symptoms of the target livestock comprises: a livestock symptom keyword library with integrated symptom classification management based on WEB cloud storage and preset symptom evaluation weight factors for each symptom severity level, retrieving each matching symptom keyword and its preset symptom evaluation weight factor corresponding to the symptom severity level in the current representation content of the symptom onset in the symptom information of the target livestock, accumulating and obtaining the current symptom severity of the target livestock, and similarly analyzing the initial symptom severity of the target livestock according to the initial representation content of the symptom onset in the symptom information of the target livestock; Searching whether there are keywords of life-threatening diseases in the current manifestation content of the target livestock's disease onset, so as to analyze the current urgency factor of the target livestock's disease; According to the current and initial severity of the symptoms of the target livestock, the symptom development coefficient of the target livestock is analyzed, and the coefficient is added to the current symptom urgency factor of the target livestock to obtain the current symptom urgency of the target livestock.
5. A real-time follow-up management method for medication for livestock breeding diseases according to claim 3, characterized in that: The monitoring of the improvement of the symptoms of the target livestock within the preset period includes: collecting the symptoms of the target livestock at the end of the preset period, analyzing the severity of the symptoms of the target livestock at the end of the preset period and urgency of the condition , build a matrix based on the current severity and urgency of the disease in the target livestock , the matrix determinant calculation value is used as the evaluation index of the improvement of the disease status of the target livestock within the preset period .
6. A real-time follow-up management method for livestock breeding disease medication according to claim 5, characterized in that: The monitoring of the drug residue status of the target livestock within the preset period includes: collecting excrement samples of the target livestock during the preset period, monitoring the residual concentration of the therapeutic drug therein, screening the maximum value therefrom and performing ratio analysis with the preset reasonable excretion residual concentration threshold of the therapeutic drug stored in the WEB cloud, and using the ratio analysis calculated value as an evaluation index of the drug residue status of the target livestock during the preset period .
7. A real-time follow-up management method for medication for livestock breeding diseases according to claim 6, characterized in that: The determination of whether there is a need to regulate the initial medication interval of the target livestock treatment drug includes: the product of the current urgency of the target livestock's disease and the severity of the disease is recorded as ; like , If the preset calculation tolerance deviation threshold is set, it means that the target livestock has recovered after taking the preset cycle of therapeutic drugs and no longer needs to take the drugs. It is judged that there is a need to adjust the initial medication interval of the target livestock therapeutic drugs, and the adjustment medication interval is automatically set to NULL; like and , it means that the target livestock has improved its symptoms after taking the preset cycle of therapeutic drugs but has not yet recovered, the residual concentration of therapeutic drugs in excreta is normal, and there is no need to adjust the initial medication interval of the target livestock therapeutic drugs; like and , it means that the target livestock has improved its symptoms after taking the preset cycle of therapeutic drugs but has not yet recovered, the residual concentration of therapeutic drugs in excreta is abnormal, and there is a need to adjust the initial medication interval of the target livestock therapeutic drugs and the regulation direction is upward; like and , it means that the symptoms of the target livestock have not improved after taking the therapeutic drugs for the preset period, the residual concentration of the therapeutic drugs in the excreta is normal, and there is a need to adjust the initial medication interval of the target livestock therapeutic drugs and the regulation direction is downward; like and , it means that the symptoms of the target livestock have not improved after taking the therapeutic drugs for the preset period, the residual concentration of the therapeutic drugs in the excrement is abnormal, and there is a need to adjust the initial medication interval of the target livestock therapeutic drugs and the regulation direction is upward.
8. A real-time follow-up management method for medication for livestock breeding diseases according to claim 7, characterized in that: The determining of the regulating medication interval of the next preset cycle of the target livestock includes: extracting the reference duration of the single medication interval regulation of the drug stored in the WEB cloud, and if it is determined that the regulation direction of the initial medication interval of the target livestock treatment drug is upward, then accumulating the initial medication interval of the target livestock treatment drug and the reference duration of the single medication interval regulation of the drug to obtain the regulating medication interval of the next preset cycle of the target livestock; If it is determined that the regulation direction of the initial medication interval of the target livestock treatment drug is downward, the initial medication interval of the target livestock treatment drug is subtracted from the benchmark duration of the single medication interval regulation of the drug to obtain the regulated medication interval of the next preset cycle of the target livestock.
9. A real-time follow-up management method for livestock breeding disease medication according to claim 3, characterized in that: The method of determining whether the therapeutic drug is effective for the target livestock comprises: drawing a drug residue change curve for the target livestock and obtaining the corresponding best fitting function ; Extract the start and end time of the curve and end endpoint time , according to the formula Analyze the effective metabolic coefficient of therapeutic drugs for target livestock; Calculate the growth rate of the target livestock's disease improvement evaluation index in each preset period relative to the previous preset period, and calculate the effective improvement coefficient of the therapeutic drug on the target livestock's disease through mean calculation ; Will , The products of the corresponding preset weights are accumulated respectively. If the accumulated value is greater than or equal to the threshold value of the drug symptomatic effectiveness evaluation standard stored in the WEB cloud, it is judged that the therapeutic drug has symptomatic effectiveness for the target livestock, otherwise it is judged that it does not have symptomatic effectiveness.
10. A real-time follow-up management method for medication for livestock breeding diseases according to claim 9, characterized in that: The method of drawing the drug residue change curve of the target livestock comprises: substituting the drug residue status evaluation index of the target livestock in each preset period into a rectangular coordinate system with time as the horizontal axis, the preset period as the unit horizontal axis span, and the drug residue status evaluation index as the vertical axis, so as to draw the drug residue change curve of the target livestock.
Citation Information
Patent Citations
Method for measuring and calculating use reduction of antibacterial agent in live pig breeding process
CN116646094A
Medication guidance and monitoring system and method suitable for respiratory disease patients
CN118315015A
System for registration of medicaments
WO2019238878A1
Cited By
Veterinary drug parameter regulation and control optimization method based on artificial intelligence integrated service
CN120072187A
